LS is associated with an increased predisposition to different cancer types, primarily colon cancer (occurring in 46–61% of individuals with a pathogenic MLH1 variant) or endometrial cancer (occurring in 34–54% of individuals with a pathogenic MLH1 variant) (2, 21). Here, MLH1 is linked to cancer.